MENU
KPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kiora Pharmaceuticals (KPRX) Ownership - Who owns Kiora Pharmaceuticals?
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
332 Encinitas Boulevard
Phone
+1 858 224-9600
Employees
12
Web
https://www.kiorapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.75M
P/E Ratio
3.10
Total Cash
29.04M
Projected Growth
N/A
Total Debt
72.64K
Revenue
16M
Risk (Beta)
-1.06
Dividend Yield
N/A
Total Cash/Share
9.68
Total Debt/Equity
N/A
Revenue/Share
4.88 USD as % of share price
Fundamentals
KPRX
Capitalization
9.75M
P/E Ratio
3.10
Risk (Beta)
-1.06
Dividend Yield
N/A
Total Cash
29M
Total Cash/Share
9.68
Total Debt
72.6K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.88%
Revenue
16M
ROE
N/A
Book Value
30M
P/B Ratio
0.32
Cash Flow
N/A
Earnings
1.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
268K
Current Ratio
8.97
Current Revenue Per Employee
1333333.40
Dividends Per Share - Security
N/A
EBITDA
2.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
20.40
Shares Held By Institutions
4.26M
Shares Outstanding - Current
3M
Total Liabilities
8.48M
Total Volume MTD
N/A
Value
1
Gain YTD
-10.606
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products to treat eye diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
332 Encinitas Boulevard
Phone
+1 858 224-9600
Employees
12
Web
https://www.kiorapharma.com